The results illustrated that the RNA level of MALAT1 in ESCA (esophageal cancer), LAML (acute myeloid leukemia), and STAD (stomach adenocarcinoma) was higher than normal tissues. Here, MALAT1 is linked to gastric adenocarcinoma.